Biotechnology company's shares dive 67% after drug failure.
Dobson
R
R
D001709:Biotechnology / Q000191:economics*; D003132:Commerce; D004345:Drug Industry / Q000191:economics*; D004791:Enzyme Inhibitors / Q000191:economics; D006801:Humans; D006877:Hydroxamic Acids / Q000191:economics; D017211:Treatment Failure
D004791:Enzyme Inhibitors; D006877:Hydroxamic Acids; C100342:marimastat